Roche's SARS-CoV-2 Antigen Test Receives CE mark For Self Testing of COVID-19 at Home
Shots:
- Roche received a CE mark for its SARS-CoV-2 Ag self-test nasal at home setting for COVID 19. The test will be available in countries accepting the CE mark
- The early version of the test is available in the EU under special approval pathways since Feb- 2021. The test can be performed by individuals using nasal swap & can deliver results in 15mins
- The test demonstrates 91.1% relative sensitivity and 99.6 % overall relative specificity from the combined study. Additionally- Roche offers NAVIFY Pass digital solution that enables individuals to share their test results and vaccine status through a unique QR code
Ref: Roche | Image: Roche
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com